How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00669806%3A_____%2F23%3A10465126" target="_blank" >RIV/00669806:_____/23:10465126 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/23:00133367 RIV/00216208:11130/23:10465126 RIV/00216208:11120/23:43925899 RIV/00216208:11140/23:10465126 and 2 more
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=wZ.1kgbk._" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=wZ.1kgbk._</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.euros.2023.05.011" target="_blank" >10.1016/j.euros.2023.05.011</a>
Alternative languages
Result language
angličtina
Original language name
How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration
Original language description
An updated Council of the EU recommendation on cancer screening was adopted in December 2022 during the Czech EU presidency. The recommendation included prostate cancer as a suitable target disease for organised screening, and invited countries to proceed with piloting and further research. To support further discussions and actions to promote early detection of prostate cancer, an international conference in November 2022 (Prostaforum 2022) resulted in a joint declaration. Here we describe the EU policy background, summarise the preparation of the declaration and the key underlying evidence and expert recommendations, and report the text of the declaration. The declaration summarises the striking inequalities in prostate cancer burden in Europe and calls on all stakeholders to consider and support concrete steps for advancement of organised early detection of prostate cancer. Our aim is to request endorsement of the text and potential initiation of practical actions by all stakeholders to support the aims of the declaration. Patient summary: Prostate cancer is among the most frequent cancers and is one of the most common causes of cancer death among men. The European Union has recommended new pilot programmes for prostate cancer screening. The Prostaforum 2022 declaration invites all stakeholders to support this new recommendation with specific steps.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30217 - Urology and nephrology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
European Urology Open Science
ISSN
2666-1691
e-ISSN
2666-1683
Volume of the periodical
53
Issue of the periodical within the volume
July
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
3
Pages from-to
106-108
UT code for WoS article
001055274700001
EID of the result in the Scopus database
2-s2.0-85161548000